GRANTS

195 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional)

Sponsor: National Institute on Aging, National Cancer Institute

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional)

Sponsor: National Institutes of Health, National Institute on Aging

Award: NIA intends to commit $2 million in total costs in FY 2018 to fund two or three awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: February 21, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not A

Sponsor: National Institute on Aging

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. Note new SBIR/STTR standard due dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not A

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. Note new SBIR/STTR standard due dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: October 17, 2018; October 17, 2019, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.

BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $8 million to fund three to six awards.

Due Date: December 20, 2017, and December 11, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early.

BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trials Not Allowed)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $4 million to fund six to 12 awards.

Due Date: December 11, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early.

Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21)

Sponsor: National Institute of Mental Health

Award: The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Due Date: November 8. 2017. Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01)

Sponsor: National Institute of Mental Health, National Center for Complementary and Integrative Health, National Eye Institute, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute of Biomedical Imaging and Bioengineering, Eunice Kennedy Shriver National Institute of Child Health and Human Development , National Institute on Drug Abuse, National Institute on Deafness and Other Communication Disorders, National Institute of Neurological Disorders and Stroke

Award: Issuing IC and partner components intend to commit an estimated total of $4 million to fund between three and seven awards.

Due Date: November 13, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for the funding opportunity announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp)

Sponsor: National Institute of Mental Health

Due Date: NIMH accepts and reviews applications on a continuous basis until April 1 of each fiscal year. Applications received after April 1 will be considered for funding in the next fiscal year. Earlier submission is strongly encouraged. Applications for FY 18 funds should be submitted no later than April 1, 2018. Applications for FY 19 funds should be submitted no later than April 1, 2019. Applications for FY 20 funds should be submitted no later than April 1, 2020. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Current Filters

No filters selected

Filter By